05:03 PM EDT, 05/07/2025 (MT Newswires) -- Revolution Medicines ( RVMD ) reported a Q1 net loss late Wednesday of $1.13 per diluted share, widening from a loss of $0.70 a year earlier.

Analysts polled by FactSet expected a loss of $1.12.

The company did not report any revenue for the quarter ended March 31.

The company expects its current cash, cash equivalents and marketable securities of $2.1 billion to fund operations into the second half of 2027.